Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8777) 8777
Publication (861) 861
Book Chapter (104) 104
Dissertation (104) 104
Book Review (73) 73
Conference Proceeding (27) 27
Web Resource (5) 5
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5584) 5584
index medicus (3848) 3848
hbv (3292) 3292
hepatitis b (3159) 3159
female (2924) 2924
hepatitis b virus (2909) 2909
male (2908) 2908
hepatitis b virus - genetics (2616) 2616
adult (2482) 2482
middle aged (2204) 2204
gastroenterology & hepatology (2038) 2038
virology (1885) 1885
infection (1669) 1669
hepatitis (1563) 1563
health aspects (1411) 1411
dna (1213) 1213
dna, viral - blood (1176) 1176
genotype (1121) 1121
hepatocellular-carcinoma (1110) 1110
aged (1074) 1074
antiviral agents - therapeutic use (1045) 1045
lamivudine (1036) 1036
infectious diseases (1023) 1023
hepatitis b - virology (1018) 1018
hepatitis b virus - isolation & purification (997) 997
surface-antigen (956) 956
hepatitis b, chronic - virology (946) 946
hepatitis b, chronic - drug therapy (926) 926
hepatitis b virus - immunology (922) 922
hbv dna (916) 916
hepatitis b surface antigens - blood (873) 873
virus diseases (873) 873
digestive system diseases (852) 852
mutation (846) 846
liver (830) 830
analysis (820) 820
adolescent (802) 802
hbv infection (799) 799
hepatitis b virus - drug effects (793) 793
therapy (789) 789
prevalence (768) 768
risk factors (740) 740
animals (735) 735
hepatocellular carcinoma (726) 726
hepatitis b virus - physiology (724) 724
dna, viral - genetics (717) 717
viral load (716) 716
replication (706) 706
young adult (694) 694
hepatitis b - epidemiology (683) 683
immunology (677) 677
polymerase chain reaction (675) 675
antigens (648) 648
hepatitis-b-virus (644) 644
infections (643) 643
antiviral agents (633) 633
chronic hepatitis b (616) 616
treatment outcome (614) 614
interferon (587) 587
hbsag (579) 579
hbv-dna (578) 578
hcv (569) 569
hepatitis b - immunology (567) 567
microbiology (563) 563
viruses (563) 563
hepatitis b e antigens - blood (553) 553
hiv (553) 553
molecular sequence data (550) 550
mutations (544) 544
deoxyribonucleic acid--dna (537) 537
dna, viral - analysis (530) 530
risk (521) 521
pharmacology & pharmacy (520) 520
genetic aspects (515) 515
hepatitis b antibodies - blood (508) 508
expression (498) 498
epidemiology (484) 484
liver cancer (472) 472
hepatitis b - complications (469) 469
virus-infection (464) 464
natural-history (458) 458
hepatitis b - diagnosis (457) 457
antiviral agents - pharmacology (453) 453
hepatitis b, chronic - immunology (451) 451
hepatitis b surface antigen (448) 448
lamivudine - therapeutic use (448) 448
hepatitis b - drug therapy (447) 447
care and treatment (446) 446
oncology (444) 444
research (441) 441
cancer (435) 435
cirrhosis (430) 430
retrospective studies (421) 421
gastroenterology and hepatology (417) 417
vaccination (416) 416
base sequence (411) 411
biochemistry & molecular biology (406) 406
genotypes (402) 402
hepatitis b virus - classification (394) 394
carcinoma, hepatocellular - virology (388) 388
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8300) 8300
Korean (177) 177
Japanese (165) 165
Chinese (145) 145
French (62) 62
Turkish (34) 34
Spanish (31) 31
German (29) 29
Polish (13) 13
Russian (11) 11
Portuguese (9) 9
Persian (5) 5
Italian (2) 2
Slovenian (2) 2
Croatian (1) 1
Czech (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: A community-based study
by Chen, Ping and Xie, Qinfen and Lu, Xuan and Yu, Chengbo and Xu, Kaijin and Ruan, Bing and Cao, Hongcui and Gao, Hainv and Li, Lanjuan
Medicine (United States), ISSN 0025-7974, 08/2017, Volume 96, Issue 33, p. e7766
This study aimed to investigate the correlation between quantitative hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA levels, and to determine... 
serological test | immune tolerant phase of HBV infection | hepatitis B virus deoxyribonucleic acid | hepatitis B e antigen | E-ANTIGEN | MEDICINE, GENERAL & INTERNAL | THERAPY | VIRUS INFECTION | CHRONIC HEPATITIS-B | POSITIVE PATIENTS | NATURAL-HISTORY | PCR | DNA, Viral - blood | Cross-Sectional Studies | China | Humans | Middle Aged | Polymerase Chain Reaction | Adult | Female | Male | Hepatitis B virus - metabolism | Hepatitis B e Antigens - blood | Serologic Tests | Care and treatment | Research | Hepatoma | DNA | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus
by Qi, Yonghe and Gao, Zhenchao and Xu, Guangwei and Peng, Bo and Liu, Chenxuan and Yan, Huan and Yao, Qiyan and Sun, Guoliang and Liu, Yang and Tang, Dingbin and Song, Zilin and He, Wenhui and Sun, Yinyan and Guo, Ju-Tao and Li, Wenhui
PLoS Pathogens, ISSN 1553-7366, 10/2016, Volume 12, Issue 10, p. e1005893
Hepatitis B virus (HBV) infection of hepatocytes begins by binding to its cellular receptor sodium taurocholate cotransporting polypeptide (NTCP), followed by... 
HEPATOCYTE CULTURES | PERSISTENCE | PLUS-STRAND DNA | POL-KAPPA | MICROBIOLOGY | ENVELOPE PROTEINS | GENOME | REPAIR | VIROLOGY | HBV REPLICATION | VIRAL-DNA | INFECTION | PARASITOLOGY | Blotting, Southern | Cell Line | Hepatitis B - metabolism | Enzyme-Linked Immunosorbent Assay | Hepatitis B - genetics | Virus Replication - genetics | Humans | DNA, Viral - metabolism | DNA, Circular - genetics | Gene Knockout Techniques | DNA, Circular - metabolism | Transfection | Fluorescent Antibody Technique | Hepatitis B virus - genetics | Polymerase Chain Reaction | Hepatocytes - virology | RNA, Small Interfering | DNA-Directed DNA Polymerase - metabolism | Hepatitis B virus - metabolism | DNA, Viral - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake
by Lambert, Marie-Pierre and Paliwal, Anupam and Vaissière, Thomas and Chemin, Isabelle and Zoulim, Fabien and Tommasino, Massimo and Hainaut, Pierre and Sylla, Bakary and Scoazec, Jean-Yves and Tost, Jörg and Herceg, Zdenko
Journal of Hepatology, ISSN 0168-8278, 2010, Volume 54, Issue 4, pp. 705 - 715
Background & Aims Hepatocellular carcinoma (HCC) is one of the most frequent human cancers and a major cause of cancer-related death worldwide. The major risk... 
Gastroenterology and Hepatology | Cirrhosis | Alcohol intake | HCV infection | Concurrent hypermethylation | HBV infection | DNA methylation | Hepatocellular carcinoma | PROMOTER HYPERMETHYLATION | TUMOR-SUPPRESSOR GENES | PATTERNS | HEPATOCARCINOGENESIS | LUNG-CANCER | COLORECTAL-CANCER | LIVER | SUSCEPTIBILITY LOCUS | HEPATITIS-B | GASTROENTEROLOGY & HEPATOLOGY | CELL | RNA-Binding Proteins - genetics | Humans | Middle Aged | Liver Neoplasms - complications | Male | DNA Primers - genetics | DNA, Neoplasm - chemistry | Hepatitis B - complications | DNA Methylation | Carcinoma, Hepatocellular - complications | Base Sequence | Carcinoma, Hepatocellular - genetics | Tumor Suppressor Proteins - genetics | Adult | Female | Hepatitis C - complications | Glutathione S-Transferase pi - genetics | Liver Neoplasms - genetics | Risk Factors | Gene Silencing | Phosphoproteins - genetics | DNA-Binding Proteins - genetics | Alcohol Drinking - adverse effects | Aged | DNA, Neoplasm - genetics | Receptors, Nicotinic - genetics | Alcoholism | Oncology, Experimental | Genes | Development and progression | Hepatoma | Drinking of alcoholic beverages | Research | Risk factors | Liver cancer | DNA | Genetic aspects | Hepatitis C virus | Hepatitis C | Methylation | Health aspects | Liver cirrhosis | Hepatitis B | Cancer | RNA-Binding Proteins | Liver Neoplasms | Alcohol Drinking | Life Sciences | Phosphoproteins | DNA, Neoplasm | DNA-Binding Proteins | Receptors, Nicotinic | DNA Primers | Glutathione S-Transferase pi | Carcinoma, Hepatocellular | Tumor Suppressor Proteins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
by Kennedy, Edward M and Bassit, Leda C and Mueller, Henrik and Kornepati, Anand V.R and Bogerd, Hal P and Nie, Ting and Chatterjee, Payel and Javanbakht, Hassan and Schinazi, Raymond F and Cullen, Bryan R
Virology, ISSN 0042-6822, 2014, Volume 476, pp. 196 - 205
Abstract Hepatitis B virus (HBV) remains a major human pathogen, with over 240 million individuals suffering from chronic HBV infections. These can persist for... 
Infectious Disease | Antiviral | DNA editing | Lentiviral vector | cccDNA | HBV | CRISPR/Cas | CccDNA | SYSTEM | ASSAY | HIGH-THROUGHPUT | PERSISTENCE | LATENT | STEP | VIROLOGY | GENE | Gene Targeting - methods | Hepatitis B - therapy | Down-Regulation | Humans | Bacterial Proteins - genetics | DNA, Viral - metabolism | Hepatitis B - virology | Hepatitis B virus - physiology | Streptococcus pyogenes - genetics | Deoxyribonuclease I - metabolism | Virus Replication | CRISPR-Associated Proteins - metabolism | Streptococcus pyogenes - enzymology | CRISPR-Cas Systems | Clustered Regularly Interspaced Short Palindromic Repeats | Hepatitis B virus - genetics | Bacterial Proteins - metabolism | DNA, Viral - genetics | Nucleases | Molecular genetics | RNA | Analysis | DNA | Hepatitis B virus | Health aspects | Hepatitis B | Index Medicus | CRISPR | Cas | antiviral | lentiviral vector
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Serum hepatitis B Virus DNA, RNA, and HBsAg: Which correlated better with intrahepatic covalently closed circular DNA before and after nucleos(t)ide analogue treatment?
by Gao, Yuhua and Li, Yutang and Meng, Qinghua and Zhang, Zhanqing and Zhao, Ping and Shang, Qinghua and Li, Yue and Su, Mingze and Li, Tong and Liu, Xueen and Zhuang, Hui
Journal of Clinical Microbiology, ISSN 0095-1137, 10/2017, Volume 55, Issue 10, pp. 2972 - 2982
The study was designed to investigate whether serum hepatitis B virus (HBV) RNA is a strong surrogate marker for intrahepatic HBV covalently closed circular... 
Covalently closed circular DNA | HBV DNA | Nucleos(t)ide analogue | Hepatitis B surface antigen | Chronic hepatitis B | HBV RNA | chronic hepatitis B | PREDICTOR | HBEAG | hepatitis B surface antigen | MICROBIOLOGY | NUCLEIC-ACIDS | LAMIVUDINE | THERAPY | nucleos(t) ide analogue | CLINICAL MARKER | SURFACE-ANTIGEN | INFECTION | CCCDNA ACTIVITY | covalently closed circular DNA | Liver - virology | Nucleosides - therapeutic use | Antiviral Agents - therapeutic use | Humans | Middle Aged | DNA, Circular - genetics | Male | RNA, Viral - blood | Hepatitis B, Chronic - diagnosis | Hepatitis B Surface Antigens - blood | DNA, Viral - blood | Hepatitis B, Chronic - virology | Young Adult | Nucleotides - therapeutic use | RNA, Viral - genetics | DNA, Circular - blood | Adolescent | Hepatitis B virus - genetics | Adult | Female | Hepatitis B virus - isolation & purification | DNA, Viral - genetics | Hepatitis B e Antigens - blood | nucleos(t)ide analogue | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text QDs-DNA nanosensor for the detection of hepatitis B virus DNA and the single-base mutants
by Wang, Yi and Wang, Xiang and Lou, Xinhui and Guo, Qingchuan and Fang, Zheng and Zhong, Xinhua and Mao, Hongju and Jin, Qinghui and Wu, Lei and Zhao, Hui and Zhao, Jianlong
Biosensors and Bioelectronics, ISSN 0956-5663, 2010, Volume 25, Issue 8, pp. 1934 - 1940
We report here a quantum dots-DNA (QDs-DNA) nanosensor based on fluorescence resonance energy transfer (FRET) for the detection of the target DNA and single... 
Quantum dots (QDs) | Mutation | Hepatitis B virus (HBV) | Fluorescence resonance energy transfer (FRET) | DNA | ELECTROCHEMISTRY | CHEMISTRY, ANALYTICAL | ASSAY | IN-SITU HYBRIDIZATION | RESONANCE ENERGY-TRANSFER | SENSOR | NANOSCIENCE & NANOTECHNOLOGY | CDS NANOCRYSTALS | CDTE | BIOPHYSICS | FLUORESCENCE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | QUANTUM-DOT-DONOR | NANOTUBES | FRET | Reproducibility of Results | Fluorescence Resonance Energy Transfer - instrumentation | DNA Mutational Analysis - instrumentation | Nanotechnology - instrumentation | DNA, Viral - analysis | Equipment Design | Oligonucleotide Array Sequence Analysis - instrumentation | Quantum Dots | Sensitivity and Specificity | Hepatitis B virus - genetics | Biosensing Techniques - instrumentation | DNA, Viral - genetics | Equipment Failure Analysis | Genetic research | Fluorescence | Hepatitis B virus | Ligases | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Chemiluminescence analysis for HBV-DNA hybridization detection with magnetic nanoparticles based DNA extraction from positive whole blood samples
by He, Nongyue and Wang, Fang and Ma, Chao and Li, Chuanyan and Zeng, Xin and Deng, Yan and Zhang, Liming and Li, Zhiyang
Journal of Biomedical Nanotechnology, ISSN 1550-7033, 02/2013, Volume 9, Issue 2, pp. 267 - 273
Molecular detection of HBV has a significant impact on prognosis and therapy of the disease. In this paper, a sensitive nucleic acid detection method of HBV... 
Chemiluminescence | Hybridization | Magnetic Nanoparticles | HBV-DNA | IRON-OXIDE NANOPARTICLES | MEDICINE, RESEARCH & EXPERIMENTAL | MICROSPHERES | NUCLEIC-ACID | CHRONIC HEPATITIS-B | NANOSCIENCE & NANOTECHNOLOGY | CANCER | AMPLIFICATION | NANOSPHERES | CONTRAST | THERANOSTICS | UPDATE | Nucleic Acid Hybridization | Temperature | Humans | DNA, Viral - isolation & purification | Luminescent Measurements - methods | Genome, Human - genetics | DNA, Viral - blood | Magnetite Nanoparticles - chemistry | Time Factors | Electrophoresis, Agar Gel | Hepatitis B virus - genetics | Polymerase Chain Reaction | Biotin - metabolism | DNA, Viral - genetics
Journal Article
Details down arrow
8. Full Text Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg‐negative patients
by Lin, L.Y and Wong, V.W.S and Zhou, H.J and Chan, H.Y and Gui, H.L and Guo, S.M and Wang, H and Huang, L and Bao, S.S and Xie, Q and Chan, H.L.Y
Journal of Medical Virology, ISSN 0146-6615, 09/2010, Volume 82, Issue 9, pp. 1494 - 1500
Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is responsible for viral persistence. This study aimed to investigate the serum surrogate... 
hepatitis B virus (HBV) | cccDNA | liver biopsy | hepatitis B surface antigen (HBsAg) | Liver biopsy | Hepatitis B virus (HBV) | Hepatitis B surface antigen (HBsAg) | MANAGEMENT | PREDICTOR | SUSTAINED RESPONSE | QUANTITATION | HBSAG LEVELS | VIROLOGY | PEGINTERFERON ALPHA-2A | LIVER | HBV DNA | INFECTION | Liver - virology | Humans | Middle Aged | Male | Virus Assembly | Hepatitis B virus - physiology | Hepatitis B Surface Antigens - blood | DNA, Viral - blood | Hepatitis B, Chronic - virology | DNA, Circular - blood | Hepatitis B virus - genetics | Adult | Female | Hepatitis B, Chronic - blood | Hepatitis B virus - isolation & purification | Hepatitis B e Antigens - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Control of cccDNA function in hepatitis B virus infection
by Levrero, Massimo and Pollicino, Teresa and Petersen, Jorg and Belloni, Laura and Raimondo, Giovanni and Dandri, Maura
Journal of Hepatology, ISSN 0168-8278, 2009, Volume 51, Issue 3, pp. 581 - 592
The template of hepatitis B virus (HBV) transcription, the covalently closed circular DNA (cccDNA), plays a key role in the life cycle of the virus and permits... 
Gastroenterology and Hepatology | Covalently closed circular DNA | cccDNA function | Chronic hepatitis B infection | Hepatitis B virus | CLOSED CIRCULAR DNA | CHRONIC HBV INFECTION | CHROMATIN-STRUCTURE | HEPADNAVIRUS INFECTIONS | HEPATOCYTE TURNOVER | PLASMACYTOID DENDRITIC CELLS | LARGE ENVELOPE PROTEIN | VIRAL-DNA | IN-VIVO | EPIGENETIC REGULATION | GASTROENTEROLOGY & HEPATOLOGY | Antiviral Agents - pharmacology | DNA, Viral - drug effects | Antiviral Agents - therapeutic use | Epigenesis, Genetic | Humans | DNA, Circular - physiology | Hepatitis B - virology | DNA, Circular - drug effects | DNA, Viral - physiology | Hepatitis B virus - physiology | Hepatitis B - physiopathology | Hepatitis B - drug therapy | Hepatitis B virus - genetics | Virus Replication - physiology | Liver cancer | Cellular proteins | Chromatin | Control | RNA | Circular DNA | Gene expression | Health aspects | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients
by Boyd, Anders and Lacombe, Karine and Lavocat, Fabien and Maylin, Sarah and Miailhes, Patrick and Lascoux-Combe, Caroline and Delaugerre, Constance and Girard, Pierre-Marie and Zoulim, Fabien
Journal of Hepatology, ISSN 0168-8278, 10/2016, Volume 65, Issue 4, pp. 683 - 691
In the presence of highly-potent antivirals, persistence of hepatitis B virus (HBV) is most well-characterized by covalently-closed circular DNA (cccDNA) and... 
Nucleoside/nucleotide analogue | Hepatitis B virus | cccDNA | Intrahepatic HBV-DNA | Exponential decay | CLOSED CIRCULAR DNA | ACTIVATION | HEPATITIS-B-VIRUS | HEPATOCELLULAR-CARCINOMA | VIREMIA | THERAPY | REPLICATION | INHIBITION | SURFACE-ANTIGEN | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | HIV Infections | Tenofovir | Coinfection | Hepatitis B e Antigens | DNA, Circular | Humans | Antiviral Agents | DNA, Viral | Hepatitis B | Antiviral agents | DNA synthesis | HIV (Viruses) | DNA | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Monitoring of hepatitis b virus (HBV) DNA and risk of HBV reactivation in B-cell lymphoma: A prospective observational study
by Kusumoto, Shigeru and Tanaka, Yasuhito and Suzuki, Ritsuro and Watanabe, Takashi and Nakata, Masanobu and Takasaki, Hirotaka and Fukushima, Noriyasu and Fukushima, Takuya and Moriuchi, Yukiyoshi and Itoh, Kuniaki and Nosaka, Kisato and Choi, Ilseung and Sawa, Masashi and Okamoto, Rumiko and Tsujimura, Hideki and Uchida, Toshiki and Suzuki, Sachiko and Okamoto, Masataka and Takahashi, Tsutomu and Sugiura, Isamu and Onishi, Yasushi and Kohri, Mika and Yoshida, Shinichiro and Sakai, Rika and Kojima, Minoru and Takahashi, Hiroyuki and Tomita, Akihiro and Maruyama, Dai and Atsuta, Yoshiko and Tanaka, Eiji and Suzuki, Takayo and Kinoshita, Tomohiro and Ogura, Michinori and Mizokami, Masashi and Ueda, Ryuzo
Clinical Infectious Diseases, ISSN 1058-4838, 2015, Volume 61, Issue 5, pp. 719 - 729
Background. There is no standard management of reactivation of hepatitis B virus (HBV) infection in HBV-resolved patients without hepatitis B surface antigen... 
Resolved HBV infection | Rituximab | HBV DNA monitoring | Preemptive antiviral therapy | HBV reactivation | resolved HBV infection | INFECTIOUS DISEASES | MALIGNANT-LYMPHOMA | MICROBIOLOGY | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | RECEIVING RITUXIMAB | CYTOTOXIC CHEMOTHERAPY | LAMIVUDINE | PROPHYLAXIS | preemptive antiviral therapy | IMMUNOGENICITY | THERAPY | INFECTION | PATIENT | rituximab | Lymphoma, B-Cell - complications | Prospective Studies | Antiviral Agents - therapeutic use | Humans | Middle Aged | Hepatitis B - virology | Hepatitis B - epidemiology | Male | Lymphoma, B-Cell - epidemiology | DNA, Viral - blood | Hepatitis B - complications | Antiviral Agents - adverse effects | Hepatitis B - drug therapy | Hepatitis B virus - genetics | Female | Lymphoma, B-Cell - virology | Aged | Antiviral agents | Care and treatment | Dosage and administration | Hepatitis B virus | Research | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Distribution of hepatitis B virus nuclear DNA
by Li, Mingming and Sohn, Ji A and Seeger, Christoph
Journal of Virology, ISSN 0022-538X, 01/2018, Volume 92, Issue 1
Chronic hepatitis B affects over 300 million people who are at risk of developing liver cancer. The basis for the persistence of hepatitis B virus (HBV) in... 
Covalently closed circular DNA | Antiviral | Hepatitis B virus | Viral persistence | Antivirals | antivirals | CLOSED CIRCULAR DNA | CELLS | PROTEIN | hepatitis B virus | viral persistence | HEPATOCYTE | INFECTED LIVER | RECOVERY | REPLICATION | VIROLOGY | antiviral | HBV | EPIDEMIOLOGY | covalently closed circular DNA | Cell Division - genetics | Antiviral Agents - pharmacology | DNA, Viral - drug effects | Antiviral Agents - therapeutic use | DNA Replication - drug effects | DNA, Viral - metabolism | DNA, Circular - isolation & purification | DNA, Circular - metabolism | Animals | Hepatitis B, Chronic - drug therapy | Virus Replication | Hepatitis B Virus, Duck - genetics | Hepatitis B virus - genetics | Hepatocytes - virology | In Situ Hybridization, Fluorescence - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A
by Wei, Xufu and Xiang, Tingxiu and Ren, Guosheng and Tan, Cui and Liu, Rui and Xu, Xiao and Wu, Zhongjun
Cellular Signalling, ISSN 0898-6568, 02/2013, Volume 25, Issue 2, pp. 439 - 446
The hepatitis B virus x (HBx) protein has been implicated in HBV-related hepatocellular carcinoma (HCC) pathogenesis. However, whether HBx regulates miRNA... 
HBV-related HCC | Methylation | miR-101 | DNMT3A | HBx | MiR-101 | HYPERMETHYLATION | MICRORNAS | IDENTIFICATION | CANCER | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | GENE | EPIGENETIC INACTIVATION | LIVER | PROMOTER | EXPRESSION | Up-Regulation | Down-Regulation | Humans | Middle Aged | Male | MicroRNAs - metabolism | Hep G2 Cells | DNA (Cytosine-5-)-Methyltransferases - metabolism | DNA (Cytosine-5-)-Methyltransferases - genetics | DNA Methylation | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Trans-Activators - genetics | Cell Line, Tumor | Adult | Female | Liver Neoplasms - pathology | Trans-Activators - metabolism | MicroRNAs - genetics | Hepatitis B virus - metabolism | Carcinoma, Hepatocellular - metabolism | Proteins | Liver cancer | MicroRNA | Methyltransferases | Glutathione transferase | Genes | DNA | Genetic research | Aspartate | Hepatitis B virus | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights